aurobindo: Aurobindo calls off Eugia Pharma Specialities sale on valuation mismatch
has abandoned the proposed sale of Eugia Pharma Specialities - which could have been the largest deal for an injectables business in India at $3 billion-$4 billion - due to valuation differences with potential buyers, multiple people…